Investors relieved at $572 million verdict in opioid trial; appeal planned

The Associated Press - August 27, 2019 2:29 pm

By The Associated Press

Johnson & Johnson investors exhaled in relief Tuesday, pushing up shares about 3 percent after an Oklahoma judge imposed a $572 million verdict late Monday for its role in the nation’s opioid crisis.

Investors had been holding their breath during a trial in which the state of Oklahoma, calling J&J a “kingpin” in the epidemic, sought up to $17 billion. The much-smaller verdict, and J&J’s immediate response that the verdict was “flawed” and it will appeal, reassured investors, for now.

“The risk of a loss was already baked into the stock price,” and this verdict doesn’t set a precedent for other cases, noted Erik Gordon, an analyst and professor at University of Michigan’s Ross School of Business.

 

Latest Stories

Former Oklahoma Teacher Charged With Rape After Alleged Relationship With Student

POTTAWATOMIE COUNTY, Oklahoma –  Prosecutors on Tuesday charged a former elementary school teacher in Pottawatomie County...

3 Arrested At Marijuana Grow Operation After Garvin Co. Deputies Received Reports Of Person Being Dragged On Road

ELMORE CITY, Oklahoma –  Three employees at a Garvin County marijuana grow operation, later determined illegal,...

Oklahoma Pardon & Parole Board Denies Clemency For Gilbert Postelle

OKLAHOMA CITY –  The Oklahoma Pardon and Parole Board voted 4 to 1 to deny clemency...